BORTEZOMIB-TEVA POWDER FOR SOLUTION FOR INJECTION 3.5MG/VIAL
Product details
Registration number: SIN16732P
Classification: Prescription Only
Active ingredients: Bortezomib (as a mannitol boronic ester)
Strength: 3.5mg/vial
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS; SUBCUTANEOUS
Registrant: TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
ATC code: L01XG01
HSA approval date: 3 March 2023
Manufacturer(s): Teva Pharmaceutical Industries Ltd.
Manufacturing country/countries: ISRAEL
What are the HSA registration number and classification for BORTEZOMIB-TEVA POWDER FOR SOLUTION FOR INJECTION 3.5MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16732P
Classification: Prescription Only
What active ingredients and strength are recorded for BORTEZOMIB-TEVA POWDER FOR SOLUTION FOR INJECTION 3.5MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Bortezomib (as a mannitol boronic ester)
Strength: 3.5mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for BORTEZOMIB-TEVA POWDER FOR SOLUTION FOR INJECTION 3.5MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS; SUBCUTANEOUS
Who is the recorded registrant for BORTEZOMIB-TEVA POWDER FOR SOLUTION FOR INJECTION 3.5MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Registrant: TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for BORTEZOMIB-TEVA POWDER FOR SOLUTION FOR INJECTION 3.5MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Teva Pharmaceutical Industries Ltd.
Manufacturing country/countries: ISRAEL
Where can I look up BORTEZOMIB-TEVA POWDER FOR SOLUTION FOR INJECTION 3.5MG/VIAL in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16732P or the exact product name BORTEZOMIB-TEVA POWDER FOR SOLUTION FOR INJECTION 3.5MG/VIAL. The general register link does not preselect this product.
What are the source dates for this BORTEZOMIB-TEVA POWDER FOR SOLUTION FOR INJECTION 3.5MG/VIAL record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this BORTEZOMIB-TEVA POWDER FOR SOLUTION FOR INJECTION 3.5MG/VIAL record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16732P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)